NOVONIX Ltd — Capital/Financing Update 2022

Oct 18, 2022

Market Announcement

==> picture [33 x 50] intentionally omitted <==

19 October 2022

==> picture [451 x 5] intentionally omitted <==

Novonix Limited (ASX: NVX) – Trading Halt

Description

The securities of Novonix Limited (‘NVX’) will be placed in trading halt at the request of NVX, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 21 October 2022 or when the announcement is released to the market.

Issued by

Zufishan Anjum

Senior Compliance Advisor, Accounting, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

19 October 2022 ASX Limited

==> picture [353 x 80] intentionally omitted <==

19 October 2022

Zufishan Anjum ASX Compliance Pty Limited Level 4, Exchange Centre 20 Bridge Street Sydney NSW 2000

By email: tradinghaltssydney@asx.com.au

Dear Zufishan,

Request for Trading Halt – Novonix Limited

Pursuant to Listing Rule 17.1, Novonix Limited (ACN 157 690 830) (ASX: NVX) ( NVX ) requests a trading halt be granted by the Australian Securities Exchange ( ASX ) in respect of NVX's ordinary shares from the commencement of trading on 19 October 2022.

For the purposes of Listing Rule 17.1, NVX provides the following information:

• 1 NVX is seeking the trading halt as it expects to make an announcement to the ASX in connection with a material funding arrangement;

• 2 NVX requests that the trading halt remain in place until the earlier of NVX making an announcement to the market about the material funding arrangement and the commencement of trading on 21 October 2022; and

• 3 NVX is not aware of any reason why the trading halt should not be granted, or of any other information available at this stage that is relevant to the trading halt.

Yours sincerely,

Suzanne Yeates Company Secretary

NOVONIX Limited (ASX: NVX) ACN 157 690 830 GPO Box 525 Brisbane Qld 4001 AUSTRALIA